Guidant (GDT) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guidant (GDT)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: D.Austin who wrote (177)	7/11/2001 9:48:20 AM
From: Lighthouse	Read Replies (2) of 235

Well now everyone hates Guidant? Downgrades galore this morning. Lowered price targets - that were a joke to begin with. Analysts on Wall Street never give good advise to the public. What a shame. I have not owned GDT in quite some time due to valuation concerns; however, that is being addressed as I write. To wit Guidant still has: 1) Strong #3 position in pacemakers 2) Very Strong #2 in ICD's 3) #1 market share in stents (until JNJ's coated stents hit the market) 4) A very strong emerging cardiac portfolio 5) Capable management 6) Huge cash generation 7) High barriers to entry Wall Street loved it at $70 and hates it at $30 - typical. Cheers,

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next